Aprea Therapeutics (NASDAQ:APRE) Earns Buy Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Aprea Therapeutics (NASDAQ:APRE – Free Report) in a research report report published on Monday morning, Benzinga reports. HC Wainwright currently has a $20.00 target price on the stock. Separately, Wedbush reiterated an outperform rating and set a $11.00 price target on shares of Aprea Therapeutics in […]
More Stories
Veritex (NASDAQ:VBTX) Shares Cross Below Two Hundred Day Moving Average – Time to Sell?
Shares of Veritex Holdings, Inc. (NASDAQ:VBTX – Get Free Report) passed below its 200-day moving average during trading on Thursday...
Sage Therapeutics (NASDAQ:SAGE) Stock Passes Below 200-Day Moving Average – What’s Next?
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday...
Castings (LON:CGS) Shares Pass Below Two Hundred Day Moving Average – Here’s Why
Castings P.L.C. (LON:CGS – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday ....
Supreme Court Agrees to Review Constitutionality of Obamacare Mandate Panel
By Matthew Vadum The U.S. Supreme Court decided Jan. 10 to review the constitutionality of an Affordable Care Act provision...
Murray Income Trust (LON:MUT) Stock Crosses Below 200-Day Moving Average – Here’s Why
Murray Income Trust PLC (LON:MUT – Get Free Report)’s stock price passed below its 200-day moving average during trading on...
Auto Trader Group (LON:AUTO) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell?
Shares of Auto Trader Group plc (LON:AUTO – Get Free Report) passed below its 200-day moving average during trading on...